A meta‐analysis demonstrated that the high Ki‐67 expression was a factor of poor prognosis for disease‐specific survival, biochemical failure‐free survival, disease‐free survival, rate of distant metastases, and overall survival after curative‐intent treatments in localized PCa patients.4 The gene discussed is MKI67; the disease is posterior cortical atrophy.